First published · Last updated
Molecular Characteristics and Clinical Outcomes of ERBB2-Activating Mutation-Positive Non-Small Cell Lung Cancer: A Japanese Nationwide Real-World Cohort
A journal article reporting a nationwide real-world cohort study in Japan of molecular features and clinical outcomes for ERBB2-activating mutation–positive non-small cell lung cancer. Publisher is listed as Elsevier BV and published 2026-09-01.
Categories: science-and-space, public-health
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 6/10
- Geographic reach
- 4/10
- Global importance
- 3/10
- Impact magnitude
- 4/10
- Positivity
- 6/10
- Urgency
- 1/10
Why it matters
The study provides nationwide molecular and outcome data for a specific mutation-positive NSCLC population in Japan.

